281 related articles for article (PubMed ID: 34182275)
1. The prevalence and predictors of extended spectrum B-lactamase urinary tract infections among emergency department patients: A retrospective chart review.
Bou Chebl R; Assaf M; Kattouf N; Abou Arbid S; Haidar S; Geha M; Makki M; Tamim H; Abou Dagher G
Am J Emerg Med; 2021 Nov; 49():304-309. PubMed ID: 34182275
[TBL] [Abstract][Full Text] [Related]
2. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
[TBL] [Abstract][Full Text] [Related]
3. Emergence of Extended-Spectrum β-Lactamase-Producing Pathogens in Community-Acquired Urinary Tract Infections Among Infants at a Pediatric Emergency Department.
Tamas V; Shah S; Hollenbach KA; Kanegaye JT
Pediatr Emerg Care; 2022 Mar; 38(3):e1053-e1057. PubMed ID: 35226630
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Tüzün T; Sayın Kutlu S; Kutlu M; Kaleli İ
Turk J Med Sci; 2019 Aug; 49(4):1206-1211. PubMed ID: 31385490
[TBL] [Abstract][Full Text] [Related]
5. Urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and antibiotic resistance.
Albaramki JH; Abdelghani T; Dalaeen A; Khdair Ahmad F; Alassaf A; Odeh R; Akl K
Pediatr Int; 2019 Nov; 61(11):1127-1132. PubMed ID: 31206219
[TBL] [Abstract][Full Text] [Related]
6. Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
Fernando MM; Luke WA; Miththinda JK; Wickramasinghe RD; Sebastiampillai BS; Gunathilake MP; Silva FH; Premaratna R
BMC Infect Dis; 2017 Feb; 17(1):138. PubMed ID: 28187754
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for community acquired pediatric urinary tract infection with extended-spectrum-β-lactamase Escherichia coli - A case-control study.
Collingwood JD; Wang L; Aban IB; Yarbrough AH; Boppana SB; Dangle PP
J Pediatr Urol; 2023 Feb; 19(1):129.e1-129.e7. PubMed ID: 36344365
[TBL] [Abstract][Full Text] [Related]
8. Risk factors of urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli in emergency department.
Lee H; Han SB; Kim JH; Kang S; Durey A
Am J Emerg Med; 2018 Sep; 36(9):1608-1612. PubMed ID: 29373168
[TBL] [Abstract][Full Text] [Related]
9. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
[TBL] [Abstract][Full Text] [Related]
10. Extended-spectrum beta-lactamase
Vachvanichsanong P; McNeil EB; Dissaneewate P
Epidemiol Infect; 2020 Dec; 149():e12. PubMed ID: 33327984
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for community acquired urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing
Zhu FH; Rodado MP; Asmar BI; Salimnia H; Thomas R; Abdel-Haq N
Infect Dis (Lond); 2019; 51(11-12):802-809. PubMed ID: 31429616
[No Abstract] [Full Text] [Related]
12. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
[TBL] [Abstract][Full Text] [Related]
13. The risk factors, antimicrobial resistance patterns, and outcomes associated with extended-spectrum β-lactamases-Producing pathogens in pediatric urinary tract infection.
He XT; Chang CN; Yu CH; Wang CC
Pediatr Neonatol; 2024 May; 65(3):242-248. PubMed ID: 37951832
[TBL] [Abstract][Full Text] [Related]
14. Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular Epidemiology.
Espinar MJ; Miranda IM; Costa-de-Oliveira S; Rocha R; Rodrigues AG; Pina-Vaz C
PLoS One; 2015; 10(8):e0134737. PubMed ID: 26237422
[TBL] [Abstract][Full Text] [Related]
15. Extended-spectrum β-lactamase-producing bacteria caused less than 5% of urinary tract infections in a paediatric emergency centre.
Jacmel L; Timsit S; Ferroni A; Auregan C; Angoulvant F; Chéron G
Acta Paediatr; 2017 Jan; 106(1):142-147. PubMed ID: 27542840
[TBL] [Abstract][Full Text] [Related]
16. Prospective cohort study of risk factors for extended-spectrum ß-lactamase-producing Escherichia coli urinary tract infections in elderly patients admitted to hospital.
Artero A; Esparcia A; Alberola J; Madrazo M; Nogueira JM; Eiros JM
Int J Clin Pract; 2017 Sep; 71(9):. PubMed ID: 28873266
[TBL] [Abstract][Full Text] [Related]
17. Relative fecal abundance of extended-spectrum-β-lactamase-producing Escherichia coli strains and their occurrence in urinary tract infections in women.
Ruppé E; Lixandru B; Cojocaru R; Büke C; Paramythiotou E; Angebault C; Visseaux C; Djuikoue I; Erdem E; Burduniuc O; El Mniai A; Marcel C; Perrier M; Kesteman T; Clermont O; Denamur E; Armand-Lefèvre L; Andremont A
Antimicrob Agents Chemother; 2013 Sep; 57(9):4512-7. PubMed ID: 23836184
[TBL] [Abstract][Full Text] [Related]
18. Does urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli show same antibiotic resistance when it recurs?
Ahn ST; Kim SW; Kim JW; Park HS; Moon DG; Oh MM
J Infect Chemother; 2019 Jul; 25(7):498-502. PubMed ID: 30852104
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features of Febrile Urinary Tract Infection Caused by Extended-spectrum Beta-lactamase-producing Escherichia Coli in Children.
Ohnishi T; Mishima Y; Takizawa S; Tsutsumi K; Amemiya A; Akiyama N; Kanna Y; Asato S; Tomita M; Ikemiyagi M; Shikoro N; Nakazawa M; Kurihara N; Kamimaki I
Keio J Med; 2020 Jun; 69(2):43-47. PubMed ID: 31474677
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.
O'Kelly F; Kavanagh S; Manecksha R; Thornhill J; Fennell JP
BMC Infect Dis; 2016 Nov; 16(1):620. PubMed ID: 27806687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
